![Ruth Adams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Ruth Adams worked as Head-Clinical Operation at Vigeo Therapeutics, Inc. Ms. Adams worked as Vice President-Clinical Operations at Nuvalent, Inc. from 2020 to 2026.
Ms. Adams completed undergraduate education at The University of Southampton.
Former positions of Ruth Adams
| Companies | Position | End |
|---|---|---|
| NUVALENT, INC. | Chief Tech/Sci/R&D Officer | 15/07/2026 |
Vigeo Therapeutics, Inc.
 Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer drugs | Chief Tech/Sci/R&D Officer | - |
Training of Ruth Adams
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vigeo Therapeutics, Inc.
Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer drugs | Health Technology |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
- Stock Market
- Insiders
- Ruth Adams
